The global electrophoresis reagents market is expected to reach USD 1.05 billion in 2020, growing at a CAGR of 5.4%. A number of factors, such as the rising incidence of infectious diseases, genetic disorders, and cancer; increasing funding for genomic and proteomic research; technological advancements; and rapidly increasing geriatric population, are fueling the growth of the electrophoresis reagents market. Moreover, the increasing demand for personalized medicine, a shift in the industry from plant-derived to genome-based drug discovery, and rapid growth in emerging countries are expected to provide growth opportunities for market players in the coming years.
In the product segment, electrophoresis gels accounted for the major market share in 2014. The large share of this segment can be attributed to the higher volume requirement of gels as compared to other reagents like dyes, buffers, and DNA Ladders. Polyacrylamide gels accounted for the largest share of the electrophoresis gels market in 2014. The polyacrylamide gels segment is also expected to grow at a higher CAGR as compared to the agarose gels segment, primarily due to its high use in protein analysis applications.
Academic & research institutions are the largest end users of electrophoresis reagents, followed by pharmaceutical & biotechnology companies. The growth in these end-user markets can majorly be attributed to the increasing research funding for proteomics & genomics and growing number of academic and industry collaboration. Gel electrophoresis accounted for the largest share of the electrophoresis reagents market, by technique. However, the capillary electrophoresis segment is expected to witness a higher growth in the coming five years primarily due to the growing use of this technique in pharmaceutical & biotechnology companies.
In 2014, North America was the largest regional segment in the global electrophoresis reagents market and this trend is expected to continue between 2015 and 2020. A number of factors, such as the highly developed life sciences industry; growing geriatric population; increasing incidence of cancer, infectious diseases, and genetic disorders; high healthcare and R&D expenditure; and the presence of a large number of electrophoresis reagents manufacturing companies in North America, are responsible for the large share of this regional segment in the global electrophoresis reagents market.
